Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (Q58376052)
Jump to navigation
Jump to search
No description defined
Language | Label | Description | Also known as |
---|---|---|---|
English | Rethinking Risk-Benefit Assessment for Phase I Cancer Trials |
No description defined |
Statements
Rethinking Risk-Benefit Assessment for Phase I Cancer Trials (English)
0 references
July 2006
0 references
24
0 references
19
0 references
2987-2990
0 references